Skip to main content
. Author manuscript; available in PMC: 2019 Nov 13.
Published in final edited form as: Nat Chem. 2019 May 13;11(6):521–532. doi: 10.1038/s41557-019-0261-6

Figure 7: Ferroptocide modulates the immune system.

Figure 7:

Ferroptocide inhibits subcutaneous 4T1 tumor growth in immunocompetent Balb/c mice (left) but not in immunodeficient SCID mice (right) as measured by tumor volume. Ferroptocide was administered intraperitoneally at 50 mg/kg, twice a week, five doses (n=7 mice per group). Data represent the mean ± s.e.m. Two-sided student t-test, P values are relative to vehicle control; ** p < 0.01, * 0.01 ≤ p < 0.05 (0.009 and 0.04 from left to right).